You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. N/A

    SBC: H&R Technical Associates, Inc.            Topic: N/A

    N/A

    STTR Phase II 1999 National Aeronautics and Space Administration
  2. N/A

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N/A

    N/A

    STTR Phase II 2000 National Aeronautics and Space Administration
  3. N/A

    SBC: ENVIRONMENTAL ENGINEERING GROUP, INC.            Topic: N/A

    N/A

    STTR Phase II 2000 Department of DefenseDefense Advanced Research Projects Agency
  4. N/A

    SBC: Generx+, Inc.            Topic: N/A

    N/A

    STTR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health
  5. Intelligent Control For Autonomous Remote Spacecraft

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N/A

    In Phase I we developed, integrated, and demonstrated a real-time adaptive navigation system, and a companion real-time adaptive guidance system for UAVs. The underlying project goal is to provide an aircraft with the capability to autonomously reroute itself in real time through dynamic hazard environments and still achieve its mission objectives. The adaptive naviagtion system uses an evolutiona ...

    STTR Phase II 2002 National Aeronautics and Space Administration
  6. P20, MOLECULAR SHORTSTOP FOR INFLAMMATORY LUNG DISEASES

    SBC: Generx+, Inc.            Topic: N/A

    The transcription factor CAAT enhancer binding protein beta (C/EBPbeta) is a key factor orchestrating the inflammatory response. Specifically, expression of the genes encoding the pro-inflammatory cytokines IL-6 and on IL-8 are regulated by C/EBPbeta. C/EBPbeta can be either an activator or an inhibitor of inflammation depending on the dominant isoforms produced. Our data indicate that airway epit ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  7. TGF-beta for Pleurodesis

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 50,000 cancer patients a year have recurrent fluid accumulation in the space between their chest wall and lung. This condition is called malignant pleural effusion (MPE). This fluid impairs breathing and worsens the quality of life in these patients. The current treatments are not ideal and include removing the fluid by repetitive needle aspiratio ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. New Broad Band Rare-Earth-Doped Glasses For Optical Fiber Communications

    SBC: KIGRE, INC.            Topic: BMDO01T001

    Kigre is developing new scalable high gain broad band rare earth doped laser oscillator/amplifier glass materials & diode pump architectures in support of high energy and high power laser applications. What's new, exciting and different about Kigre's laser glass materials and constructs is the ability to efficiently store and extract 1000-10,000x more laser power from ultra-short gain lengths and ...

    STTR Phase II 2004 Department of DefenseDefense Advanced Research Projects Agency
  9. Gene Expression and Diagnosis of Diabetes

    SBC: ARTHROCHIP, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Autoimmune diseases are difficult to diagnose, as the symptoms can be nonspecific. A single test that could readily distinguish between an autoimmune and non-autoimmune disorder would allow physicians to focus efforts on the specific disease that affects the patient. This is critical for diabetes mellitus (DM), which has two subsets, Type I and Type II. The sub ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Commercial Development of Stabilized Cellular Diagnostics and Therapeutics to Lessen Logistical Burden on the Battlefield

    SBC: Greystone Pharmaceuticals, Inc.            Topic: ST031001

    Massive blood loss is the most common cause of death in potentially survivable battlefield casualties, yet no definitive medical innovations have been made for reducing these deaths in the past several decades. It is still highly impractical to carry large volumes of refrigerated blood into battle, and substantial research for developing blood substitutes and extending the durability and portabili ...

    STTR Phase II 2005 Department of DefenseDefense Advanced Research Projects Agency
US Flag An Official Website of the United States Government